M
MedGenome Labs
A genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome
At a glance
- Founded
- 2013
- Headquarters
- Foster City, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
- PCPapillon Capital
- VIVidinovo
- EVEmerge Ventures
- SISingapore
- ICInnoVen Capital
Series B and later9 investors entered at this stage
- HLHDFC ERGO General Insurance Company Limited
Sofina- NHNovo Holdings
Sequoia- LILeapFrog Investments
- NSNovo Seeds
- MIMaj Invest
- ZCZodius Capital
International Finance Corporation
Source: Dealroom Talent Intelligence.
Global footprint
across markets
Investments and acquisitions
Disclosed deals where MedGenome Labs was the backer or acquirer, 2016–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
5 deals across MedGenome Labs's capital deployment.
Where the deals concentrate by sector, stage, and decade.
MedGenome Labs's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about MedGenome Labs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MedGenome Labs on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.